The results are sorted from lowest E-value to highest E-value. Strong classifications have a low E-value. Weak classifications have an E-value greater than 0.0001. Weak hits are shown in gray. Weak hits are not shown on the domain architecture.
The family level classification is conditional on the domain being a member of the specified superfamily. There is a possibility that the selected domain is a member of a sub-family for which no structure has yet been solved.
| Sequence: |
ENSRNOP00000023965 |
| Domain Number 1 |
Region: 517-708 |
| Classification Level |
Classification |
E-value |
| Superfamily |
Hemopexin-like domain |
6.28e-51 |
| Family |
Hemopexin-like domain |
2.01e-07 |
| Further Details: |
|
| |
| Domain Number 2 |
Region: 88-216,390-445 |
| Classification Level |
Classification |
E-value |
| Superfamily |
Metalloproteases ("zincins"), catalytic domain |
3.41e-32 |
| Family |
Matrix metalloproteases, catalytic domain |
1.15e-06 |
| Further Details: |
|
| |
| Domain Number 3 |
Region: 335-391 |
| Classification Level |
Classification |
E-value |
| Superfamily |
Kringle-like |
2.08e-21 |
| Family |
Fibronectin type II module |
0.00015 |
| Further Details: |
|
| |
| Domain Number 4 |
Region: 275-332 |
| Classification Level |
Classification |
E-value |
| Superfamily |
Kringle-like |
6.28e-21 |
| Family |
Fibronectin type II module |
0.00014 |
| Further Details: |
|
| |
| Domain Number 5 |
Region: 219-275 |
| Classification Level |
Classification |
E-value |
| Superfamily |
Kringle-like |
1.4e-20 |
| Family |
Fibronectin type II module |
0.00022 |
| Further Details: |
|
| |
| Domain Number 6 |
Region: 38-105 |
| Classification Level |
Classification |
E-value |
| Superfamily |
PGBD-like |
5.65e-18 |
| Family |
MMP N-terminal domain |
0.00012 |
| Further Details: |
|
| |
| Sequence: |
ENSRNOP00000023965 |
| Domain Number - |
Region: 448-524 |
| Classification Level |
Classification |
E-value |
| Superfamily |
beta-sandwich domain of Sec23/24 |
0.0628 |
| Family |
beta-sandwich domain of Sec23/24 |
0.033 |
| Further Details: |
|
| |